Quick Answer
Acumen Pharmaceuticals, Inc. reported Shares Outstanding of 60.58 million shares for fiscal year 2025.
Acumen Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 60.58M | +0.8% |
| 2024 | 60.09M | +3.8% |
| 2023 | 57.91M | +41.2% |
| 2022 | 41.03M | +1.4% |
| 2021 | 40.47M | +9556.6% |
| 2020 | 419,124 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 60.57M | +0.8% | +0.0% |
| June 30, 2025 | 60.57M | +0.8% | +0.0% |
| March 31, 2025 | 60.57M | +0.8% | +0.8% |
| December 31, 2024 | 60.09M | +3.8% | +0.0% |
| September 30, 2024 | 60.08M | +3.7% | +0.0% |
| June 30, 2024 | 60.08M | +46.4% | +0.0% |
| March 31, 2024 | 60.08M | +46.4% | +3.7% |
| December 31, 2023 | 57.91M | +41.2% | +0.0% |
- Acumen Pharmaceuticals, Inc. showed an increase of +0.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Acumen Pharmaceuticals, Inc.’s shares outstanding has grown by 14352.9% (from 419.1 thousand shares to 60.58 million shares).
- The most recent figure is from Acumen Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: